---
title: "Biote posts April 2026 investor presentation highlighting $192.2M 2025 revenue and $53.5M Adj. EBITDA"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/281660267.md"
description: "Biote's April 2026 investor presentation revealed 2025 revenue of $192.2M and adjusted EBITDA of $53.5M, with a 27.8% margin. The company reported over 9,200 certified practitioners and approximately 400,000 active patients as of December 31, 2025. Capital allocation actions included a $25.1M repurchase of 5.5M Class V shares and other settlements totaling $31M. For 2026, Biote aims to expand practitioner onboarding, enhance clinical decision support software, and develop higher-value offerings to drive growth."
datetime: "2026-04-03T20:13:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/281660267.md)
  - [en](https://longbridge.com/en/news/281660267.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/281660267.md)
---

# Biote posts April 2026 investor presentation highlighting $192.2M 2025 revenue and $53.5M Adj. EBITDA

**Biote posted an April 2026 investor presentation highlighting $192.2M 2025 revenue and $53.5M adjusted EBITDA.**

**Key Highlights:**

-   Posted Investor Presentation dated April 2026 on its IR website and attached as Exhibit 99.1 to the 8-K.
-   Reported 2025 results: $192.2M revenue, $53.5M Adjusted EBITDA and 27.8% Adjusted EBITDA margin.
-   Company cites \>9,200 Biote-certified practitioners and ~400,000 active patients as of Dec 31, 2025.
-   Announced capital allocation actions: ~$25.1M repurchase of ~5.5M Class V shares and other settlement repurchases totaling ~$31M.
-   Outlined 2026 priorities: expand practitioner onboarding, leverage clinical decision support software, and develop higher-value offerings to drive growth.

Original SEC Filing: biote Corp. \[ BTMD \] - 8-K - Apr. 03, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BTMD.US](https://longbridge.com/en/quote/BTMD.US.md)

## Related News & Research

- [biote shareholders elect directors and ratify Deloitte appointment](https://longbridge.com/en/news/286825538.md)
- [Transactions in connection with share buy-back program](https://longbridge.com/en/news/286746558.md)
- [Hyatt EVP David Udell disposes of 10,458 shares worth $1.8 million](https://longbridge.com/en/news/287116535.md)
- [QDRO Acquisition Sets Separate Trading for Class A Shares and Warrants on Nasdaq](https://longbridge.com/en/news/287111744.md)
- [StepStone declares USD 0.28 quarterly dividend, adds USD 0.55 supplemental payout](https://longbridge.com/en/news/287112243.md)